Comparative fertility and pregnancy outcomes after local treatment for cervical intraepithelial neoplasia and stage 1a1 cervical cancer: protocol for a systematic review and network meta-analysis from the CIRCLE group.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
21 10 2019
Historique:
entrez: 23 10 2019
pubmed: 23 10 2019
medline: 21 10 2020
Statut: epublish

Résumé

There are several local treatment methods for cervical intraepithelial neoplasia that remove or ablate a cone-shaped part of the uterine cervix. There is evidence to suggest that these increase the risk of preterm birth (PTB) and that this is higher for techniques that remove larger parts of the cervix, although the data are conflicting. We present a protocol for a systematic review and network meta-analysis (NMA) that will update the evidence and compare all treatments in terms of fertility and pregnancy complications. We will search electronic databases (CENTRAL, MEDLINE, EMBASE) from inception till October 2019, in order to identify randomised controlled trials (RCTs) and cohort studies comparing the fertility and pregnancy outcomes among different excisional and ablative treatment techniques and/or to untreated controls. The primary outcome will be PTB (<37 weeks). Secondary outcomes will include severe or extreme PTB, prelabour rupture of membranes, low birth weight (<2500 g), neonatal intensive care unit admission, perinatal mortality, total pregnancy rates, first and second trimester miscarriage. We will search for published and unpublished studies in electronic databases, trial registries and we will hand-search references of published papers. We will assess the risk of bias in RCTs and cohort studies using tools developed by the Cochrane collaboration. Two investigators will independently assess the eligibility, abstract the data and assess the risk of bias of the identified studies. For each outcome, we will perform a meta-analysis for each treatment comparison and an NMA once the transitivity assumption holds, using the OR for dichotomous data. We will use CINeMA (Confidence in Network meta-analysis) to assess the quality of the evidence for the primary outcome. Ethical approval is not required. Results will be disseminated to academic beneficiaries, medical practitioners, patients and the public. CRD42018115495.

Identifiants

pubmed: 31636110
pii: bmjopen-2018-028009
doi: 10.1136/bmjopen-2018-028009
pmc: PMC6803140
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e028009

Subventions

Organisme : Department of Health
ID : PB-PG-0816-20004
Pays : United Kingdom

Informations de copyright

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Control Clin Trials. 1986 Sep;7(3):177-88
pubmed: 3802833
Cochrane Database Syst Rev. 2015 Sep 29;(9):CD008478
pubmed: 26417855
Res Synth Methods. 2016 Mar;7(1):55-79
pubmed: 26332144
Stat Med. 2017 Apr 15;36(8):1210-1226
pubmed: 28083901
J Clin Epidemiol. 2016 Jan;69:161-9
pubmed: 26210055
Stat Med. 2012 Dec 20;31(29):3805-20
pubmed: 22763950
BMJ. 1999 Apr 3;318(7188):904-8
pubmed: 10102852
Arch Gynecol Obstet. 2014 Jan;289(1):85-99
pubmed: 23843155
Int J Epidemiol. 2012 Jun;41(3):818-27
pubmed: 22461129
BJOG. 2010 Nov;117(12):1468-74
pubmed: 20840527
BJOG. 2007 Jan;114(1):3-4
pubmed: 17233854
Stat Med. 1996 Dec 30;15(24):2733-49
pubmed: 8981683
Eur J Obstet Gynecol Reprod Biol. 2015 May;188:24-33
pubmed: 25770844
Stat Med. 2002 Nov 15;21(21):3153-9
pubmed: 12375296
Res Synth Methods. 2016 Sep;7(3):236-63
pubmed: 26754852
Cochrane Database Syst Rev. 2013 Dec 04;(12):CD001318
pubmed: 24302546
BMJ. 2008 Sep 18;337:a1284
pubmed: 18801868
BMJ. 2014 Jan 14;348:f7361
pubmed: 24423603
BMJ. 2014 Jan 14;348:f7700
pubmed: 24423750
Obstet Gynecol. 2009 Dec;114(6):1232-8
pubmed: 19935024
Res Synth Methods. 2012 Jun;3(2):80-97
pubmed: 26062083
BMJ. 2016 Oct 12;355:i4919
pubmed: 27733354
Stat Med. 2013 Dec 30;32(30):5414-29
pubmed: 24123165
BMJ. 2005 Oct 15;331(7521):897-900
pubmed: 16223826
Res Synth Methods. 2012 Jun;3(2):111-25
pubmed: 26062085
J Clin Epidemiol. 2011 Feb;64(2):163-71
pubmed: 20688472
Stat Methods Med Res. 2008 Jun;17(3):279-301
pubmed: 17925316
BMC Med. 2013 Jul 04;11:159
pubmed: 23826681
Ann Intern Med. 2013 Jul 16;159(2):130-7
pubmed: 23856683
J Clin Epidemiol. 2009 Aug;62(8):857-64
pubmed: 19157778
Syst Rev. 2015 Jan 01;4:1
pubmed: 25554246
Stat Med. 2007 Jan 15;26(1):37-52
pubmed: 16463355
BJOG. 2012 May;119(6):685-91
pubmed: 22329499
BMC Med Res Methodol. 2012 Sep 12;12:138
pubmed: 22970794
J Clin Epidemiol. 2016 Aug;76:193-9
pubmed: 26939929
Value Health. 2015 Jul;18(5):673-81
pubmed: 26297096
BMJ. 2012 Sep 04;345:e5847
pubmed: 22951549
Stat Med. 2001 Dec 30;20(24):3875-89
pubmed: 11782040
BMJ. 2014 Oct 28;349:g6192
pubmed: 25352501
Res Synth Methods. 2012 Jun;3(2):161-76
pubmed: 26062088
Cochrane Database Syst Rev. 2017 Nov 02;11:CD012847
pubmed: 29095502
BMJ. 2016 Jul 28;354:i3633
pubmed: 27469988
Lancet. 2006 Feb 11;367(9509):489-98
pubmed: 16473126
Int J Gynaecol Obstet. 2015 Feb;128(2):141-7
pubmed: 25444615
Res Synth Methods. 2019 Mar;10(1):83-98
pubmed: 30067315
BMC Med Res Methodol. 2015 Jul 31;15:58
pubmed: 26227148
BMC Med Res Methodol. 2014 Sep 19;14:106
pubmed: 25239546
BMJ. 2014 Nov 05;349:g6223
pubmed: 25378384
PLoS One. 2014 Jul 03;9(7):e99682
pubmed: 24992266
Obstet Gynecol. 2014 Apr;123(4):752-61
pubmed: 24785601
PLoS One. 2013 Oct 03;8(10):e76654
pubmed: 24098547
BMJ. 2003 Sep 6;327(7414):557-60
pubmed: 12958120

Auteurs

Antonios Athanasiou (A)

Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, Institute of Reproductive and Developmental Biology, London, UK.
West London Gynaecological Cancer Centre, Imperial College Healthcare NHS Trust, London, UK.

Areti Angeliki Veroniki (AA)

Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, Institute of Reproductive and Developmental Biology, London, UK.
School of Education, Department of Primary Education, Panepistimio Ioanninon, Ioannina, Greece.

Orestis Efthimiou (O)

Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland.

Ilkka Kalliala (I)

Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, Institute of Reproductive and Developmental Biology, London, UK.
Department of Obstetrics and Gynaecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Huseyin Naci (H)

Department of Health Policy, London School of Economics, London, UK.

Sarah Bowden (S)

Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, Institute of Reproductive and Developmental Biology, London, UK.
West London Gynaecological Cancer Centre, Imperial College Healthcare NHS Trust, London, UK.

Maria Paraskevaidi (M)

Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, Institute of Reproductive and Developmental Biology, London, UK.

Pierre Martin-Hirsch (P)

Department of Gynaecologic Oncology, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, UK.

Philip Bennett (P)

Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, Institute of Reproductive and Developmental Biology, London, UK.
West London Gynaecological Cancer Centre, Imperial College Healthcare NHS Trust, London, UK.

Evangelos Paraskevaidis (E)

West London Gynaecological Cancer Centre, Imperial College Healthcare NHS Trust, London, UK.
Department of Obstetrics and Gynaecology, University of Ioannina and University Hospital of Ioannina, Ioannina, Greece.

Georgia Salanti (G)

Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland.

Maria Kyrgiou (M)

Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, Institute of Reproductive and Developmental Biology, London, UK m.kyrgiou@imperial.ac.uk.
West London Gynaecological Cancer Centre, Imperial College Healthcare NHS Trust, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH